Helicos BioSciences (HLCSQ) 10-Q 2012 Q2 Quarterly report

EXHIBIT 32.1

CERTIFICATION

In connection with the Quarterly Report on Form 10-Q of Helicos BioSciences Corporation (the “Company”) for the quarter ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Ivan Trifunovich, the Principal Executive Officer of the Company and Jeffrey R. Moore, the Principal Financial Officer and Principal Accounting Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to our knowledge that:

(1)           the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and

(2)           the information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

Dated: August 14, 2012	/s/ IVAN TRIFUNOVICH
	Ivan Trifunovich
	President and Chief Executive Officer
	(Principal Executive Officer)
Dated: August 14, 2012	/s/ JEFFREY R. MOORE
	Jeffrey R. Moore
	Senior Vice President and Chief Financial Officer
	(Principal Financial Officer and Principal Accounting Officer)

A signed original of this written statement required by Section 906 has been provided to Helicos BioSciences Corporation and will be retained by Helicos BioSciences Corporation and furnished to the Securities and Exchange Commission or its staff upon request.